Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

1.4K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete plastid genome and phylogenetic analysis of <i>Hypericum wightianum</i> (Hypericaceae).

Mitochondrial DNA. Part B, Resources·2026
Same author

Single-Cell and Spatial Transcriptomics Unveil Key Regulators Governing Cell Differentiation for Schistosoma japonicum Sexual Development.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

N<sup>6</sup>-Methyladenosine on Key Messenger RNAs Governs Reproductive Development and Metabolic Adaptation in Human Blood Fluke.

Research (Washington, D.C.)·2026
Same author

Contraction, recombination and innovation shape the dynamic pan-plastome of Astragalus sinicus.

Communications biology·2026
Same author

Codon usage bias and molecular evolution of <i>Dnajc15</i> across avian lineages.

Frontiers in genetics·2026
Same author

Endogenous iron biomineralization in the mouse spleen of metabolic diseases.

Fundamental research·2026

Related Experiment Video

Updated: Mar 30, 2026

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
11:00

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells

Published on: October 17, 2025

493

Reassembly nanomaterials-mediated engineered bacteria lysis for reshaping immunosuppressive microenvironment.

Tingjie Zhang1, Jianke Yang1, Guofeng Cheng1

  • 1College of Marine Life Science, Ocean University of China, Qingdao, 266003, China.

Biomaterials
|March 28, 2026
PubMed
Summary

Engineered bacteria and nanomaterials deliver immune factors to tumors, enhancing cancer therapy. This hybrid system safely reshapes the tumor microenvironment, significantly reducing tumor growth and bacterial load.

Keywords:
Bacterial-nanomaterial systemsEngineered bacteria therapyIFN-γReassembly-mediated bacteria lysisReshaping immunosuppressive microenvironment

More Related Videos

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

8.5K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.5K

Related Experiment Videos

Last Updated: Mar 30, 2026

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells
11:00

3D Flipwell Engineering for Developing Asynchronous Systems for Toxicologic and Immunomodulatory Therapies in Bacterial, Gut, and Immune Cells

Published on: October 17, 2025

493
Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation
06:57

Rapid, Scalable Assembly and Loading of Bioactive Proteins and Immunostimulants into Diverse Synthetic Nanocarriers Via Flash Nanoprecipitation

Published on: August 11, 2018

8.5K
Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
10:16

Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation

Published on: October 12, 2018

8.5K

Area of Science:

  • Biomedical Engineering
  • Cancer Therapy
  • Immunology

Background:

  • Bacterial therapy shows promise for cold tumors but faces challenges like microenvironment interference and tumor-promoting metabolites.
  • Genetically modified bacteria can deliver immune activators, but control and safety remain concerns.

Purpose of the Study:

  • To develop a bacteria-nanomaterial hybrid system (IE-PPCs) for stable, controllable immune factor delivery and enhanced cancer treatment safety.
  • To engineer E. coli Nissle 1917 (EcN) to express IFN-γ and anchor it onto a nanomaterial carrier.

Main Methods:

  • Engineered EcN expressing IFN-γ, anchored onto peptide-functionalized nanomaterials (PPCs).
  • Controlled IFN-γ expression via IPTG induction.
  • Demonstrated IE-PPCs tumor homing, MMP-triggered nanostructure transformation, bacterial lysis, and immune factor release in 4T1 mouse models.

Main Results:

  • IE-PPCs selectively colonized tumors, releasing IFN-γ and bacterial lysates upon MMP-triggered lysis.
  • IFN-γ inhibited tumor proliferation; combined therapy promoted dendritic cell maturation and M1 macrophage polarization.
  • IE-PPCs plus anti-PD-L1 achieved an 89.7% anti-tumor rate with a 98.9% reduction in tumor bacterial load.

Conclusions:

  • The IE-PPCs system offers a breakthrough strategy for reshaping immunosuppressive tumor microenvironments.
  • This approach provides a safe and effective therapeutic option for cancer treatment by combining bacterial therapy and nanomaterials.